Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT05425004
Brief Summary:
A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma
Study:
NCT05425004
Study Brief:
Protocol Section:
NCT05425004